Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00700908 · ClinicalTrials.gov registry record · NA

Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT00700908: Completed NA study, sponsored by University of Minnesota.

NCT00700908 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00700908, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

Aim 1. Determine the impact of a daily, automated telephone intervention on HbA1c levels compared to standard care in older patients with type 2 diabetes. Aim 2. Determine the impact of the automated telephone intervention compared to standard care on adherence to prescribed SMBG frequency in older patients with type 2 diabetes. Aim 3. Determine the impact of the automated telephone intervention compared to standard care on self-reported diabetic control problems in older patients with type 2 diabetes. Aim 4. Determine the impact of the automated telephone intervention compared to standard care on self-reported attitudes and health beliefs concerning diabetes in older patients with type 2 diabetes

Interventions

  • BEHAVIORAL automated telephone intervention vs. usual care

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2007-06
Est. Completion 2008-06
Phase NA
University of Minnesota

966 total trials

What the finished NCT00700908 record still lists

NCT00700908 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which automated telephone intervention vs. usual care is the first listed.

NCT00700908 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00700908 about?

NCT00700908 is a clinical study titled "Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes". Aim 1. Determine the impact of a daily, automated telephone intervention on HbA1c levels compared to standard care in older patients with type 2 diabetes. Aim 2. Determine the impact of the automated telephone intervention compared to standard care on adherence to prescribed SMBG frequency in older...

What is the current status of trial NCT00700908?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2007-06. Estimated completion is 2008-06.

What interventions are being tested in trial NCT00700908?

The interventions under investigation include: automated telephone intervention vs. usual care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00700908?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00700908's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00700908, the US trial registry maintained by the National Library of Medicine. NCT00700908 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.